CARMEL, Ind., June 17, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), covering two health insurers, with approximately 700,000 total members in Connecticut and Massachusetts. This medical policy will bring our national tot ...

CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with the development and progression of neurodegenerative diseases such as Alzheimer's Disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), as well as other misfolded protein diseases, today announced that Neil Warma, Chief Execut ...

The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 treatment resulted in significant reductions in NLRP3-related biomarkers in CSF and plasma, demonstrating sustained target engagement VTX3232 is also being studied in a 12-week Phase 2 trial in participants with obesity and cardiometabolic risk factors; topl ...

Is it going to be a quiet show. There's so many things going on at the moment. Does that put a little bit of a cloud over what's going to happen.I think the accident last week obviously was a very tragic event. We are all working hard in this industry for these not to happen. So when it happens, it's a it's a big setback.But yes, we have a slow start in the show. But I think it will be a good show. As you rightly say, there are plenty of uncertainties and difficulties, but also some megatrends.More and more ...

Good evening everyone. Have you ever thought about how your body will age. Somewhere between the age of 30 and 40, we start losing muscle mass at a rate of about 1% each year.That's normal. It's called sarcopenia. We get slower. We get more limited. and we get vulnerable to diseases.On top of these physical challenges, we also have mental and psychological challenges. Anxiety and depression are on the rise and even our teenagers are now stressed. So, what if there was one habit, one practice that you can ad ...

The biopharmaceuticals industry is both exciting and risky for investors. Many leading growth stocks in the U.S. market are found in this sector, due to the significant rallies that biopharmaceutical companies experience when a key positive trial result is announced or an important drug receives government approval. On the other hand, a host of biopharma firms face near-constant threats of collapse, given that most of these companies lack sufficient revenue to sustain operations for long unless a breakthrou ...

Greetings everyone. A few years ago, we were wrapping up a vacation in Hawaii. It's a family vacation at the airport, bags in hand.I suddenly realized, oh my god, I left our passports at the hotel. Okay, happens once in a while, right. And later on, I started forgetting the names of the people I would interact with.You know, it didn't happen every day, but noticeable enough. It was there. And I asked my neurology friend, "Hey, what if this happens to me every day? I start forgetting things that normally I d ...

Let me start by asking you all something. Have you at least once in your life, I know you're all very young, but at any point in your life, have you asked yourself this question? And the question is, who am I? Who am I? Sounds like a simple question, right? You see, the moment you're born, you're welcomed into a world that pretty much tells you who you are. You are enrolled into school by the time you're just 3 or 4 years old. And there are these milestones that are set on your path. And you're expected to ...

We all understand that u European allies will have to take u much greater responsibility for our own defense. uh but uh this transition uh this handover of responsibility from United States more to Europeans will require some time and even if uh we uh adopt the decision to increase significantly defense spending even if uh we apply all uh the measures of uh flexibility and efficiency it will really take uh years uh to replace some of uh uh US strategic enablers. I understand that the United States will try ...

-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded upon top line data previously reported- NEWTOWN, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that ...